Skip to content

Clinical trials

Active, not recruiting Phase 1/2 trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 1/2 Status: Active, not recruiting Country / region: Australia Clear all

108 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20151
20163
20173
20183
20198
202015
202113
202220
202310
202421
20258
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting108

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals7
Hoffmann-La Roche6
AstraZeneca5
Merck Sharp & Dohme LLC5
Peter MacCallum Cancer Centre, Australia5
GlaxoSmithKline4
Amgen3
Eli Lilly and Company3
Genmab3
Servier Bio-Innovation LLC3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung13
Breast Neoplasms9
Pancreatic Neoplasms8
Colorectal Neoplasms7
Neoplasm Metastasis7
Neoplasms7
Multiple Myeloma6
Prostatic Neoplasms6
Stomach Neoplasms6
Melanoma5

Trials

Showing 1 to 25 of 108. Each trial links to its page on Pharma Observatory.

8 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.